Startseite UR
Publikationen von 0000-0002-1821-7887
(ORCID: 0000-0002-1821-7887)
 | Eine Stufe nach oben |
Anzahl der Einträge: 17.
Harrer, Dennis Christoph 
, Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2026)
Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias.
Frontiers in Pharmacology 17.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Reichle, Albrecht und Heudobler, Daniel
(2026)
Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid.
International Journal of Molecular Sciences 27 (2), S. 1067.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2025)
MEPED as salvage therapy for relapsed/refractory Hodgkin’s lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck.
Frontiers in Pharmacology 16.
Reuthner, Kathrin, Aubele, P., Menhart, Karin , Rath, Philipp, Harrer, D. C., Herr, Wolfgang, Hahn, Joachim, Vogelhuber, Martin, Heudobler, Daniel , Lueke, F., Reichle, Albrecht und Grube, Matthias
(2024)
Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin’s disease developing resistance to pembrolizumab.
Frontiers in Pharmacology 15.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht und Heudobler, Daniel
(2024)
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.
Frontiers in Oncology 13.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2023)
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.
Cancers 16 (1), S. 180.
Fante, Matthias A., Harrer, Dennis C., Zartner, Barbara, Lüke, Florian, Mayer, Stephanie, Menhart, Karin, Reichle, Albrecht , Herr, Wolfgang, Vogelhuber, Martin und Heudobler, Daniel
(2023)
All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma.
Frontiers in Oncology 13.
Pelliccia, Andrea , Capradossi, Francesco , Corsi, Francesca , Tarquini, Greta Deidda, Bruni, Emanuele, Reichle, Albrecht , Torino, Francesco und Ghibelli, Lina
(2023)
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition.
International Journal of Molecular Sciences 24 (3), S. 2040.
Volltext nicht vorhanden.
, Capradossi, Francesco , Corsi, Francesca , Tarquini, Greta Deidda, Bruni, Emanuele, Reichle, Albrecht , Torino, Francesco und Ghibelli, Lina
(2023)
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition.
International Journal of Molecular Sciences 24 (3), S. 2040.
Volltext nicht vorhanden.
Lüke, Florian , Harrer, Dennis Christoph, Pantziarka, Pan , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht und Heudobler, Daniel
(2022)
Drug Repurposing by Tumor Tissue Editing.
Frontiers in Oncology 2022 (12), S. 900985.
Heudobler, Daniel, Harrer, Dennis Christoph, Lüke, Florian , Einspieler, Ingo, Menhart, Karin, Hellwig, Dirk , Utpatel, Kirsten , Herr, Wolfgang und Reichle, Albrecht
(2022)
Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature.
Frontiers in Oncology 2022 (12), S. 1-7.
Heudobler, Daniel, Fante, Matthias A., Felsensteiner, Mona, Mayer, Stephanie, Gerken, Michael, Klinkhammer-Schalke, Monika, Herr, Wolfgang, Vogelhuber, Martin und Reichle, Albrecht
(2022)
All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma.
Frontiers in Oncology 2022 (12), S. 1-11.
Heudobler, Daniel, Schulz, Christian , Fischer, Jürgen R., Staib, Peter, Wehler, Thomas, Südhoff, Thomas, Schichtl, Thomas, Wilke, Jochen, Hahn, Joachim, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias , Herr, Wolfgang, Held, Swantje, Beckers, Kristine, Bouche, Gauthier und Reichle, Albrecht
(2021)
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung).
Frontiers in Pharmacology 12 (599598), S. 1-10.
Harrer, Dennis Christoph, Menhart, Karin, Mayer, Stephanie, Herr, Wolfgang, Reichle, Albrecht und Vogelhuber, Martin
(2020)
Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report.
Frontiers in Oncology 10 (585830), S. 1-4.
Lüke, Florian , Orsó, Evelyn , Kirsten, Jana, Poeck, Hendrik, Grube, Matthias, Wolff, Daniel, Burkhardt, Ralph , Lunz, Dirk, Lubnow, Matthias, Schmidt, Barbara, Hitzenbichler, Florian, Hanses, Frank, Salzberger, Bernd , Evert, Matthias, Herr, Wolfgang, Brochhausen, Christoph, Pukrop, Tobias, Reichle, Albrecht und Heudobler, Daniel
(2020)
Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells.
eJHaem 1 (1), S. 376-383.
Kattner, Anna-Sophia , Holler, Ernst, Herr, Wolfgang, Reichle, Albrecht , Wolff, Daniel und Heudobler, Daniel
(2020)
Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy.
Frontiers in Oncology 10 (443), S. 1-5.
Heudobler, Daniel, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias , Herr, Wolfgang, Gerner, Christopher , Pantziarka, Pan, Ghibelli, Lina und Reichle, Albrecht
(2019)
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction.
Frontiers in Oncology 9 (1408), S. 1-22.
Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Pukrop, Tobias, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher und Reichle, Albrecht
(2018)
Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue.
International Journal of Molecular Sciences 19 (11), S. 3540.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707